Beijing QL Biopharmaceutical Boosts Pipeline with RMB 200 Million Series B+ Round
Beijing QL Biopharmaceutical Co., Ltd., a Chinese biopharmaceutical company, has reportedly secured nearly RMB 200...
QL Biopharmaceutical
Beijing’s QL Bio Secures Tens of Millions in Funding for Proteomics Platform Upgrade
QL Bio, a Beijing-based proteomics testing company, has reportedly secured tens of millions of renminbi...
QL Biopharm Raises Series B Funding for Protein Drug Development
QL Biopharm, a Beijing-based developer of Escherichia coli-based protein drugs, has reportedly raised RMB 100...